Abbott Unveils Breakup, Plans To Settle Alleged Marketing Misdeeds | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

Abbott Unveils Breakup, Plans To Settle Alleged Marketing Misdeeds

Abbott Labs is splitting up. The diversified maker of medical products will become two companies: one focused on brand-name prescription drugs and the second on the other stuff, including medical devices, diagnostic tests and baby formula.

It's a big deal, and Forbes' Matt Herper explains the logic behind it: Investors aren't giving drugmakers much respect, so separating the businesses could give a lift to the future stock of the faster-growing non-drug business.

But there's some other darker news on the drug front that got overshadowed by the company's restructuring. Abbott said it's putting aside $1.5 billion to cover an expected settlement with the federal government of claims that the company went way too far in selling the seizure drug Depakote.

Some former Abbott employees filed a lawsuit, later joined by the feds, that alleges the company promoted Depakote for unapproved uses, such as treatment of Alzheimer's dementia, and that it paid kickbacks to doctors to boost sales.

In a release on company earnings, Abbott disclosed the potential settlement, saying that company expenses now include "$1.5 billion of litigation reserves" related to ongoing settlement discussions related to Depakote.

In an August filing Abbott said:

The United States Department of Justice, through the United States Attorney for the Western District of Virginia, is investigating Abbott's sales and marketing activities for Depakote. The government is seeking to determine whether any of these activities violated civil and/or criminal laws, including the Federal False Claims Act, the Food and Drug Cosmetic Act, and the anti-Kickback Statute in connection with Medicare and/or Medicaid reimbursement to third parties. Discussions are ongoing in an effort to resolve potential civil and criminal claims arising from this matter. Abbott is unable to predict the outcome of this matter or to estimate the range or amount of possible loss and no loss reserves have been recorded for this exposure.

Copyright 2011 National Public Radio. To see more, visit http://www.npr.org/.

NPR

Snubs And Successes: 6 Lessons Learned From This Year's Emmy Nominations

HBO's Game of Thrones emerged as the most-nominated series with 19 nods for the Primetime Emmy Awards, but new series such as FX's Fargo and HBO's True Detective scored, too.
NPR

'Captain Pizza' Saves The Day, But Doesn't Save Himself A Slice

A pilot found himself hungry during a midflight delay. But instead of just buying a pizza for himself, he bought 50 pizzas for the entire Frontier Airlines plane.
NPR

In Texas, Obama Sets Stage To Answer 'Do-Nothing' Congress

President Obama knows he's unlikely to get support from Texas' predominantly Republican congressional delegation, but being rebuffed will make it easier for him to shift blame to the GOP.
NPR

A New Device Lets You Track Your Preschooler ... And Listen In

LG's KizON wristband lets you keep tabs on your child. But some experts say such devices send the wrong message about the world we live in. And the gadgets raise questions about kids' privacy rights.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.